Founded in 1873 in the canton of Aargau, Siegfried has grown from a small operation of 12 employees to a global Contract Development and Manufacturing Organization (CDMO) with a significant impact in the pharmaceutical industry.
Today, with a presence in Evionnaz (canton of Valais) since 66 years, Siegfried stands out for its specialized services in the development and industrialization of active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s journey from a local manufacturer to a global player is marked by organic growth and strategic acquisitions and an unyielding commitment to quality and innovation.
Siegfried’s acquisition of the Evionnaz site in 2015, previously known as Orgamol and later BASF, marked a strategic move that positioned the company as a key player in the CDMO domain. Under the direction of Marcel Signer, the site head, Siegfried Evionnaz has excelled in developing new projects and scaling up industrialization efforts. The site currently employs 380 professionals and is in the process of constructing a new R&D building, which is set to double the company’s development capacity and create around 40 new high-value jobs.
Siegfried’s success in Evionnaz is largely attributed to the expertise and flexibility of its workforce. The company’s slogan, “expect more,” resonates with its ability to meet diverse client needs. Siegfried’s uniqueness lies in its comprehensive service range, extending from small-scale production to large-scale manufacturing involving several tons, alongside regulatory and quality support.
An attractive work-life balance in the canton of Valais
The Valais region offers an exceptional quality of life, contributing to a favorable work-life balance for Siegfried’s employees. The stunning natural backdrop of the mountains and the region’s overall environment serve as daily motivators for the workforce.
Siegfried maintains close relationships with local universities and authorities, focusing on developing training programs and adapting to evolving market needs. Contacts with institutions like the HES-SO and EPFL in Lausanne further reinforce Siegfried’s commitment to innovation and sustainable development.
Today, sustainability is a key value embedded in Siegfried’s operations, reflecting the company’s pioneering efforts in this area. This commitment is in line with current societal expectations and demands from clients, demonstrating the company’s dedication to responsible and sustainable pharmaceutical manufacturing.
A legacy of innovation and excellence
With its comprehensive range of services for the pharmaceutical industry, Siegfried is well-positioned to continue its legacy of innovation and excellence. The company’s focus on sustainability, coupled with the passion and flexibility of its workforce, makes Siegfried a prominent and respected figure in the pharmaceutical sector. As Siegfried continues to expand and evolve, its commitment to quality, innovation, and sustainability ensures a promising future in the ever-changing landscape of global healthcare.
